Antidepressant monotherapy vs sequential pharmacotherapy and mindfulness-based cognitive therapy, or placebo, for relapse prophylaxis in recurrent depression.
about
Interventions for preventing relapse and recurrence of a depressive disorder in children and adolescentsCitalopram versus other anti-depressive agents for depressionMindfulness-based cognitive therapy for depression: trends and developmentsTreatment-refractory anxiety; definition, risk factors, and treatment challengesCritical analysis of the efficacy of meditation therapies for acute and subacute phase treatment of depressive disorders: a systematic reviewPrevention of Relapse and Recurrence in Adults with Major Depressive Disorder: Systematic Review and Meta-Analyses of Controlled TrialsMeditation programs for psychological stress and well-being: a systematic review and meta-analysisCollaboration in Mindfulness-Based Cognitive TherapyInvestigating the phenomenological matrix of mindfulness-related practices from a neurocognitive perspective.A Randomized Controlled Trial of Mindfulness-Based Cognitive Therapy for Treatment-Resistant Depression.A narrative review of yoga and mindfulness as complementary therapies for addiction.Meditation as a potential therapy for autism: a review.Mood-linked responses in medial prefrontal cortex predict relapse in patients with recurrent unipolar depressionComputational psychiatry as a bridge from neuroscience to clinical applications.Trait mindfulness as a limiting factor for residual depressive symptoms: an explorative study using quantile regressionThe DARE study of relapse prevention in depression: design for a phase 1/2 translational randomised controlled trial involving mindfulness-based cognitive therapy and supported self monitoring.Studies of long-term use of antidepressants: how should the data from them be interpreted?Blood transcriptomic biomarkers in adult primary care patients with major depressive disorder undergoing cognitive behavioral therapy.Preventing depressive relapse and recurrence in higher-risk cognitive therapy responders: a randomized trial of continuation phase cognitive therapy, fluoxetine, or matched pill placeboMindful mood balance: a case report of Web-based treatment of residual depressive symptomsPreventing relapse in recurrent depression using mindfulness-based cognitive therapy, antidepressant medication or the combination: trial design and protocol of the MOMENT study.Integrative medicine for treating depression: an update on the latest evidence.A two-factor model of relapse/recurrence vulnerability in unipolar depression.Cognitive Therapy to Prevent Depressive Relapse in Adults.A pilot study of group mindfulness-based cognitive therapy (MBCT) for combat veterans with posttraumatic stress disorder (PTSD)Self-referential thinking, suicide, and function of the cortical midline structures and striatum in mood disorders: possible implications for treatment studies of mindfulness-based interventions for bipolar depression.World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders. part 2: maintenance treatment of major depressive disorder-update 2015.The role of complementary, alternative, and integrative medicine in personalized health care.A Preliminary Study: Efficacy of Mindfulness-Based Cognitive Therapy versus Sertraline as First-line Treatments for Major Depressive Disorder.Relative efficacy of mindfulness-based relapse prevention, standard relapse prevention, and treatment as usual for substance use disorders: a randomized clinical trial.Treatment-specific changes in decentering following mindfulness-based cognitive therapy versus antidepressant medication or placebo for prevention of depressive relapseRelapse prevention in major depressive disorder: Mindfulness-based cognitive therapy versus an active control condition.Depressive symptom deterioration among predominantly Hispanic diabetes patients in safety net careA randomized clinical trial of mindfulness-based cognitive therapy versus unrestricted services for health anxiety (hypochondriasis)Increased Gamma Brainwave Amplitude Compared to Control in Three Different Meditation Traditions.Mindfulness-based cognitive therapy (MBCT) reduces the association between depressive symptoms and suicidal cognitions in patients with a history of suicidal depressionMindfulness-based cognitive therapy for residual depressive symptoms and relapse prophylaxisPsychological and neural mechanisms of trait mindfulness in reducing depression vulnerability.Mindfulness starts with the body: somatosensory attention and top-down modulation of cortical alpha rhythms in mindfulness meditationGetting better with age: the relationship between age, acceptance, and negative affect.
P2860
Q24197563-7FFB1F51-C174-479B-BDA0-83CA38F2DC18Q24202141-C48EA70D-3659-483E-9B0D-08AF21D18C9CQ26747698-F33B91E8-E234-4802-9C70-A3BA2C89DD91Q26798229-8D0CDDC2-3164-4E80-BCDE-C2807A94B529Q28083967-331CFABF-CD3F-4ADD-BB59-66FC1DB13641Q28088645-A74E10C4-4CA5-4919-BE4C-D4935902E4F9Q28305336-557604AE-4A07-4FD4-9C46-C00F9A4595E6Q29011756-116A7B47-8F3C-471E-8B57-0EF6BC5F36EBQ29305322-4953F75E-1572-4270-845A-E3A9E588DB85Q30383857-D860E786-FD7A-4C2D-9444-E0D1EF73B72BQ30430144-59A6403C-2C6B-46EF-9E4C-38813DCAB22CQ30464350-76E0FA67-B1B6-4B9C-BF42-E88457E62EF3Q30502895-7A443EEA-A531-46CD-BF55-7589617F70CEQ33724477-580CED49-9D85-4DB6-9AEA-984F4CF9347AQ33837975-17AAC2D6-DE9F-476F-87DC-3EB4389B5C2CQ34133355-9FC38109-97B8-417E-BF21-05FDEAEBE0C6Q34148012-D1601E97-D135-428C-9A4C-E5F564BB058FQ34345609-EB61BAD8-E2D6-4619-8212-AB6E5F801DE3Q34378212-83F0250D-5E15-4980-B769-2A7307BFB5E8Q34386697-1C0248CF-D053-4FDF-B1A6-CC1AE7B33D21Q34394278-2760C16A-22F7-478C-813A-D879F69B53DFQ34940629-262817FB-D472-4291-AA1F-5EDFFEF59880Q35095145-EF87A302-5A04-46FA-BECC-49541F0710F9Q35115733-9E093D24-B590-4011-AFF5-DFC4E962F890Q35216665-206F5230-36FF-4A54-B4DD-3232BFF92807Q35232291-EFD957F9-B4A5-411C-93E3-11B5BBC03B16Q35560309-E3B2F083-919F-45D9-865B-77FEB60C9EFFQ35614187-0313BC2F-1F8A-4ACC-9BE6-9789F8A947FAQ35737882-F80D7D92-1EDD-4181-949F-9D870EA300DAQ35811275-09BE051A-86ED-4B13-AAC1-8BCB591B73CDQ36002607-4FAA8688-5BE8-4C8B-A645-8700F464414FQ36063613-27314ABB-C662-4370-8166-EF0DC79B4C5BQ36074262-8053534D-83F0-4D13-A719-716ACA59382FQ36256745-1721D5AD-DFE4-4B0D-9FBD-64C47D1C87ACQ36258906-A4CA21E6-1991-43B9-BBDE-64E8AAF1AFFDQ36306962-75E9E2EF-53E2-4587-BBA8-72FAC81CE1BEQ36446456-E3D1BD91-220C-4E89-9902-581170109974Q36522236-0B165F43-7AAE-467A-9106-D0801E3D30A0Q36605976-7173D8AE-D6E3-42DA-AB01-1B033DE3F121Q36721555-3AC89802-3BFA-45C7-9D0E-D06F6622B2AC
P2860
Antidepressant monotherapy vs sequential pharmacotherapy and mindfulness-based cognitive therapy, or placebo, for relapse prophylaxis in recurrent depression.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Antidepressant monotherapy vs ...... laxis in recurrent depression.
@ast
Antidepressant monotherapy vs ...... laxis in recurrent depression.
@en
type
label
Antidepressant monotherapy vs ...... laxis in recurrent depression.
@ast
Antidepressant monotherapy vs ...... laxis in recurrent depression.
@en
prefLabel
Antidepressant monotherapy vs ...... laxis in recurrent depression.
@ast
Antidepressant monotherapy vs ...... laxis in recurrent depression.
@en
P2093
P2860
P1433
P1476
Antidepressant monotherapy vs ...... laxis in recurrent depression.
@en
P2093
Glenda MacQueen
Lawrence Martin
Peter Bieling
Richard Bloch
Robert Cooke
Robert D Levitan
Trevor Young
Zindel V Segal
P2860
P304
P356
10.1001/ARCHGENPSYCHIATRY.2010.168
P407
P577
2010-12-01T00:00:00Z